AI MARKET SCANNING

Jazz Pharmaceuticals plc

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +1.04%
MAX GAP RECORD +7.36%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $JAZZ
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 03, 2026 Earnings Release 2026-08-03 (AFTER CLOSE)
+1.51%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
+7.36%
Feb 24, 2026 Earnings Release 2026-02-24 (AFTER CLOSE)
+3.55%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
+3.66%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
-4.99%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
-5.09%
Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE)
+0.59%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
+4.76%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $JAZZ

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC);…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗